Details for Patent: 10,737,028

✉ Email this page to a colleague

Patent 10,737,028 protects AUVI-Q, EVZIO, EVZIO (AUTOINJECTOR), and NALOXONE HYDROCHLORIDE (AUTOINJECTOR), and is included in four NDAs.

This patent has one hundred and six patent family members in fourteen countries.

Patent landscape, scope, and claims:

Title:	Devices, systems and methods for medicament delivery
Abstract:	A method includes moving an actuation lock of a medical injector from a first position to a second position. The actuation lock has an extended portion disposed between a shoulder of a housing and the base when the actuation lock is in the first position. The extended portion is spaced apart from the base when the actuation lock is in the second position. A distal end portion of a base, which is movably coupled to an end portion of the housing, is placed into contact with a body. The base is actuated after the placing to release an energy from an energy storage member within the housing to produce a force to move a needle from a first needle position to a second needle position. At least a portion of the needle extends through the base when the needle is in the second needle position.
Inventor(s):	Edwards; Eric S. (Moseley, VA), Edwards; Evan T. (Charlotttesville, VA), Licata; Mark J. (Doswell, VA), Meyers; Paul F. (Fishers, IN)
Assignee:	kaleo, Inc. (Richmond, VA)
Application Number:	16/426,412
Patent Claim Types: see list of patent claims	Device;
More… ↓ ⤷ Subscribe

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Kaleo Inc	AUVI-Q	epinephrine	SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS	201739-003	Nov 17, 2017		RX	Yes	No	10,737,028	⤷ Subscribe	Y				⤷ Subscribe
Kaleo Inc	AUVI-Q	epinephrine	SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS	201739-002	Aug 10, 2012	BX	RX	Yes	Yes	10,737,028	⤷ Subscribe	Y				⤷ Subscribe
Kaleo Inc	AUVI-Q	epinephrine	SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS	201739-001	Aug 10, 2012	BX	RX	Yes	No	10,737,028	⤷ Subscribe	Y				⤷ Subscribe
Kaleo Inc	EVZIO	naloxone hydrochloride	SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS	205787-001	Apr 3, 2014		DISCN	Yes	No	10,737,028	⤷ Subscribe	Y				⤷ Subscribe
Kaleo Inc	EVZIO (AUTOINJECTOR)	naloxone hydrochloride	SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS	209862-001	Oct 19, 2016		DISCN	Yes	No	10,737,028	⤷ Subscribe	Y				⤷ Subscribe
Kaleo Inc	NALOXONE HYDROCHLORIDE (AUTOINJECTOR)	naloxone hydrochloride	SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS	215457-001	Feb 28, 2022		DISCN	Yes	No	10,737,028	⤷ Subscribe	Y				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2004325202	⤷ Subscribe
Australia	2006210865	⤷ Subscribe
Australia	2007245139	⤷ Subscribe
Australia	2009200841	⤷ Subscribe
Australia	2009246525	⤷ Subscribe
Australia	2012201481	⤷ Subscribe
Australia	2015264857	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration